Vaping found to be three times more effective than NRT in landmark quit smoking study

Ryan J. Courtney, Bridget C. Howard, Daniel Barker, Dennis Petrie, Ron Borland, Anthony Shakeshaft, Coral Gartner, Colin Mendelsohn, Veronica C. Boland, Alexandra Henderson, Robyn L. Richmond, Piotr Tutka, Felix Naughton, Wayne Hall, Nicholas Zwar, Michael Farrell, Richard P. Mattick, Hayden McRobbie

New research published in the Annals of Internal Medicine shows that vaping products are three times more effective than nicotine replacement therapy (NRT) for helping smokers from disadvantaged backgrounds quit. The trial demonstrated a 28.4% quit rate for vaping compared to 9.6% for NRT after six months.

Participants chose their device and flavour, while using evidence-based nicotine strengths, highlighting the importance of personalised, practical support in smoking cessation. This study reinforces vaping’s role as a safe and effective tool to reduce smoking rates, particularly among priority populations.

Importantly, the study found fewer adverse reactions were experienced in the vaping group which further highlights vaping's safety profile as a harm reduction method.

Read more on the study here.